ProGel (Pharmaceuticals) Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $108K

  • Investors
  • 1

ProGel (Pharmaceuticals) General Information

Description

Manufacturer of alginate microgels intended to provide functional foods, healthier supplements & smarter pharmaceutics. The company's microgel is based on the calcium alginate gel system that is designed to break and release its contents in the intestinal environment and protect against denaturation and deactivation by gastric enzymes and the low pH environment, enabling pharmaceuticals, food and nutraceuticals companies to offer tastier functional foods, healthier supplements, and smarter pharmaceutics.

Contact Information

Website
www.progel.com.au
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • General Purpose South Building
  • University of Queensland, Saint Lucia
  • Brisbane, Queensland 4067
  • Australia
+61 0437
Primary Industry
Drug Delivery
Other Industries
Other Consumer Non-Durables
Parent Company
PERKii
Vertical(s)
LOHAS & Wellness, Manufacturing, Life Sciences
Corporate Office
  • General Purpose South Building
  • University of Queensland, Saint Lucia
  • Brisbane, Queensland 4067
  • Australia
+61 0437

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProGel (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Jan-2024 $108K Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
5. Later Stage VC (Series B) 30-Jun-2014 Completed Generating Revenue
4. Grant 16-Jan-2012 Completed Generating Revenue
3. Early Stage VC (Series A) 03-Jun-2010 Completed Generating Revenue
2. Seed Round 01-Jan-2009 $400K $400K Completed Startup
1. University Spin-Out 01-Jan-2009 Completed Startup
To view ProGel (Pharmaceuticals)’s complete valuation and funding history, request access »

ProGel (Pharmaceuticals) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view ProGel (Pharmaceuticals)’s complete cap table history, request access »

ProGel (Pharmaceuticals) Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

ProGel (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013351919-A1 A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active Active 29-Nov-2012
AU-2013351919-B2 A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active Active 29-Nov-2012
EP-2925302-A1 A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active Inactive 29-Nov-2012
EP-2925302-A4 A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active Inactive 29-Nov-2012
US-20150306038-A1 A microparticle composition comprising a probiotic, cross-linkable reagent and an emulsion containing a hydrophobic active Inactive 29-Nov-2012 A61K35/747
To view ProGel (Pharmaceuticals)’s complete patent history, request access »

ProGel (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProGel (Pharmaceuticals) Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AustralianSuper Limited Partner Minority
Brisbane Angels Angel Group Minority
Plug and Play Accelerator/Incubator
Uniquest Accelerator/Incubator Minority
Uniseed Venture Capital Minority
To view ProGel (Pharmaceuticals)’s complete investors history, request access »

Ready to get started?

Request a free trial

ProGel (Pharmaceuticals) FAQs

  • When was ProGel (Pharmaceuticals) founded?

    ProGel (Pharmaceuticals) was founded in 2009.

  • Where is ProGel (Pharmaceuticals) headquartered?

    ProGel (Pharmaceuticals) is headquartered in Brisbane, Australia.

  • What is the size of ProGel (Pharmaceuticals)?

    ProGel (Pharmaceuticals) has 3 total employees.

  • What industry is ProGel (Pharmaceuticals) in?

    ProGel (Pharmaceuticals)’s primary industry is Drug Delivery.

  • Is ProGel (Pharmaceuticals) a private or public company?

    ProGel (Pharmaceuticals) is a Private company.

  • What is the current valuation of ProGel (Pharmaceuticals)?

    The current valuation of ProGel (Pharmaceuticals) is .

  • What is ProGel (Pharmaceuticals)’s current revenue?

    The current revenue for ProGel (Pharmaceuticals) is .

  • How much funding has ProGel (Pharmaceuticals) raised over time?

    ProGel (Pharmaceuticals) has raised $1.85M.

  • Who are ProGel (Pharmaceuticals)’s investors?

    AustralianSuper, Brisbane Angels, Plug and Play, Uniquest, and Uniseed have invested in ProGel (Pharmaceuticals).

  • When was ProGel (Pharmaceuticals) acquired?

    ProGel (Pharmaceuticals) was acquired on 31-Jan-2024.

  • Who acquired ProGel (Pharmaceuticals)?

    ProGel (Pharmaceuticals) was acquired by PERKii.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process